The mechanism by which GLP-1 agonists reduce alcohol intake in humans is currently unknown, though a recent RCT reported reduced alcohol cue reactivity in the nucleus accumbens (NAc), a key region associated with alcohols rewarding properties, after treatment with the GLP-1 agonist Exenatide 11
PlexusDx handles this coordination seamlessly: after your consultation, your compounded semaglutide or other GLP-1 medication is prepared and shipped directly to you, with dosing instructions provided by your clinical team
The patient needs a custom dosage or form that is not commercially available
You feel the relief almost right away, no more heavy head, dry mouth, or drained feeling
The dosage of lipotropic injections depends on their constituents and the patient
In order to win your case, you have to question these experts